Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

RVC study reveals benefits of feline epicardial pacemakers
Cats are less likely to be considered for EP implantation.
EPs improved severe heart conditions in cats.

Research from the Royal Veterinary College (RVC) has found that epicardial pacemakers (EPs) can result in positive outcomes for cats suffering from severe heart conditions.

Findings revealed that EP implantation supported artificial cardiac pacing (ACP), which was effective in resolving symptoms such as abnormally slow heart rates (bradyarrhythmia).

Cats are less likely to be considered for EP implantation, as they are better at tolerating bradyarrhythmia. It is usually reserved for cats displaying symptoms such as loss of consciousness, lethargy or a congestive heart.

There was also a lack of research into performing the procedure and the outcomes on quality of life.

A research team, led by Matteo Rossanese, investigated the outcomes of implantations for 39 cats across four animal hospitals. Using a two-part survey, the team sought to identify the clinical signs and health-related quality of life by measuring cat activity and owner satisfaction.

The findings confirmed that EP was a beneficial surgery for cats, contributing to a longer, better quality of life for cats.

The primary reasons that cats were referred for treatment included bradycardia and collapsing episodes. A third-degree atrioventricular block was found to be the most common indicator of pacemaker placement.

Owners reported a good improvement in their cat’s condition, rating their satisfaction at 9.9 out of 10.

The research team says that their findings also highlight the importance of a joined up approach between cardiology and cardiothoracic specialists in these cases.

Dr Rossanese, senior lecturer in small animal soft tissue surgery, said: “I am incredibly proud of the work our team has done to explore the use of epicardial pacemakers in cats.

“This study not only highlights the potential for significant improvements in quality of life for feline patients but also provides valuable evidence to guide clinicians in making confident decisions about this life-changing procedure.

“It has been a privilege to lead this study alongside a dedicated team of colleagues, and I hope these findings will encourage further advancements in veterinary cardiology.”

The full study can be found in the Journal of the American Veterinary Medical Association.

Image © RVC

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
VMD issues guidance on AVM-GSL packaging

The Veterinary Medicines Directorate (VMD) has shared advice on its requirements for medicines considered AVM-GSL.

The guidance explains the information that should be on the outer package, and sets out the typical maximum pack size for an AVM-GSL product. It also describes the user-friendly language, structure and phrases required on packaging and product leaflets.

AVM-GSL products do not require discussion between the purchaser and a veterinary professional. This means that clear product information is needed to support sales choices.

The information will be useful for submitting new products to the AVM-GSL category and lowering the distribution category of products from NFA-VPS to AVM-GSL.

The VMD's guidance can be accessed here.